The Daily Dose: Bacterial herd immunity, assays on the move, and some Social Realism

Improving diagnostics in resource poor places: Breaking with the standard lateral flow assays or microfluidics that characterize point-of-care diagnostic tools, researchers optimized inkjet-printed digital microfluidic (DMF) cartridges and a portable control system to perform serological immunoassays in remote settings.

The bacterial herds: Humans and eukaryotes aren’t the only ones that rely on herd immunity to ensure the safety of large groups. This study examines how CRISPR can play a role in protecting colonies of bacteria during a phage epidemic.

Staphylococcus aureus Bacteria
Scanning electromicrograph of Staphylococcus aureus bacteria. Credit: NIAID

Synthesizing a kinder, gentler IL-2: Synthorx raised $63 million that will allow it to pursue its synthetic cytokines pipeline. Of particular interest is Synthorin, its knock-off interleukin-2 product. In a perfect world, the synthetic version would increase the efficacy of immuno-oncological treatments without the harsh side effects of IL-2, namely an unwanted bout of immunosuppression.

Sketching a famine: An exhibition of Indian Social Realist artist Chittaprosad’s political sketches and etchings are on display at the Fuller Building in New York City. Of particular interest are his portrayals of the terrible famine that gripped Bangladesh in 1943.

IMAGE SOURCE: Delhi Art Gallery

The Scientific Inquirer needs your support. Please visit our Patreon page and discover ways that you can make a difference.

Leave a Reply

%d bloggers like this: